By analyzing R2: Genomics Analysis and Visualization Platform database, we found that ITGA2 is significantly upregulated in human GBM tumor tissues and high ITGA2 expression has a negative impact on GBM patient survival, suggesting ITGA2 as a promising therapeutic target for GBM. This evidence concerns the gene ITGA2 and glioblastoma.